98%
921
2 minutes
20
Background: Automated seizure detection based on scalp electroencephalography (EEG) can significantly accelerate the epilepsy diagnosis process. However, most existing deep learning-based epilepsy detection methods are deficient in mining the local features and global time series dependence of EEG signals, limiting the performance enhancement of the models in seizure detection.
Methods: Our study proposes an epilepsy detection model, CMFViT, based on a Multi-Stream Feature Fusion (MSFF) strategy that fuses a Convolutional Neural Network (CNN) with a Vision Transformer (ViT). The model converts EEG signals into time-frequency domain images using the Tunable Q-factor Wavelet Transform (TQWT), and then utilizes the CNN module and the ViT module to capture local features and global time-series correlations, respectively. It fuses different feature representations through the MSFF strategy to enhance its discriminative ability, and finally completes the classification task through the average pooling layer and the fully connected layer.
Results: The effectiveness of the model was validated by experimental evaluations on the publicly available CHB-MIT dataset and the Kaggle 121 people epilepsy dataset. The model achieved 98.85% classification accuracy and other excellent metrics in single-subject experiments on the CHB-MIT dataset, and also demonstrated strong performance in cross-subject experiments on the Kaggle dataset. Ablation experiments demonstrate the complementary roles of the CNN and ViT modules, and their integration significantly improves detection accuracy and generalization. Comparisons with other methods highlight the advantages of the CMFViT model.
Conclusions: The CMFViT model provides an efficient, accurate, and innovative solution for complex EEG signal analysis and seizure detection tasks for single and cross-subjects while laying the foundation for developing real-time, accurate seizure detection systems.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329966 | PMC |
http://dx.doi.org/10.1186/s12967-025-06862-z | DOI Listing |
Eur J Case Rep Intern Med
August 2025
Division of Internal Medicine, University Hospital of Basel, Basel, Switzerland.
Unlabelled: Encephalitis is a potentially life-threatening condition with infectious or autoimmune aetiologies. Autoimmune encephalitis includes paraneoplastic variants associated with specific onconeural antibodies such as anti-Hu, frequently linked to malignancies. Herpes simplex virus type 1 (HSV-1) is the leading infectious cause in adults.
View Article and Find Full Text PDFJ Neural Eng
September 2025
University of Pennsylvania, 3400 Spruce Street, Philadelphia, Pennsylvania, 19104-6243, UNITED STATES.
New implantable and wearable devices hold great promise to help patients manage their seizure disorders. One proposed application is measuring the rate of interictal epileptiform discharges as a biomarker of medication levels and seizure risk. This study aims to determine whether interictal epileptiform spike rates (spikes) are independently associated with anti-seizure medication (ASM) levels and evaluate whether spike rates are a reliable biomarker for ASM levels.
View Article and Find Full Text PDFJ Feline Med Surg
September 2025
Department for Small Animals, Veterinary Faculty, Leipzig University, Leipzig, Germany.
ObjectivesThe objective of this study was to evaluate the occurrence of voltage-gated potassium channel (VGKC) antibodies and the pattern of MRI changes in cats with complex partial seizures with orofacial involvement (CPSOFI), as well as to investigate whether there are factors influencing survival that could be used as prognostic markers in those cats.MethodsCats with CPSOFI were identified retrospectively. The following data were retrieved from the hospital database: signalment, age at first seizure and presentation, the presence of antibodies against VGKC (leucine-rich glioma inactivating factor 1 (LGI1), contactin-associated protein 2 (CASPR2)) and cerebrospinal fluid (CSF) analysis findings.
View Article and Find Full Text PDFEpilepsy Res
August 2025
University of Colorado School of Medicine, Aurora, CO, USA.
Objectives: Responsive neurostimulation (RNS) electrocorticographic (ECoG) data may have a role in objectively assessing the efficacy of add-on antiseizure medications (ASMs). This retrospective, multicenter, observational, 24-week study is the first to report the effects of cenobamate on RNS-detected events (RDE).
Methods: Patients included adults (≥18 years) with a history of recurrent focal seizures and implanted RNS who initiated adjunctive cenobamate ≥ 3 months after RNS implant between 4/1/20-12/15/23 and who received ≥ 2 weeks of cenobamate (≥50 mg/day).
Epilepsy Behav
September 2025
Neurology Division, Department of Pediatrics, Phramongkutklao Hospital, Bangkok, Thailand. Electronic address:
Background: Levetiracetam commonly causes neuropsychiatric adverse events (NPAEs) in pediatric patients, including irritability and aggression. This study evaluated pyridoxine supplementation for reducing levetiracetam-related NPAEs in children and adolescents with epilepsy.
Methods: We conducted a prospective, double-blind, randomized, placebo-controlled trial at Phramongkutklao Hospital, Thailand (January-June 2024).